1. Home
  2. NPKI vs PLRX Comparison

NPKI vs PLRX Comparison

Compare NPKI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$14.49

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
PLRX
Founded
1932
2015
Country
United States
United States
Employees
510
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
74.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
PLRX
Price
$14.49
$1.26
Analyst Decision
Strong Buy
Hold
Analyst Count
3
4
Target Price
$14.17
$2.67
AVG Volume (30 Days)
762.0K
423.4K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
$11.70
N/A
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.95
$1.09
52 Week High
$16.50
$1.95

Technical Indicators

Market Signals
Indicator
NPKI
PLRX
Relative Strength Index (RSI) 42.51 58.14
Support Level $14.20 $1.13
Resistance Level $15.08 $1.37
Average True Range (ATR) 0.55 0.05
MACD -0.10 0.01
Stochastic Oscillator 0.91 96.55

Price Performance

Historical Comparison
NPKI
PLRX

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: